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Abstract
Background: Choriocarcinoma is a very rare cause of ocular metastasis. Only 18 male patients have been reported
on, 4 of whom survived, but with significant loss of vision.
Case presentation: A 26-year-old Caucasian man, suffering from testicular choriocarcinoma with pulmonary,
cerebral, renal, hepatic and osseous metastases, underwent left radical orchiectomy. While being treated with
chemotherapy, he presented with loss of vision in the left eye. Ophthalmoscopy revealed bilateral non-pigmented,
hemorrhagic choroidal tumours, compatible with secondary lesions. Continued chemotherapy and stereotactic
radiotherapy of the skull and spine lead to full remission with excellent vision, after more than 4 years of follow up.
Conclusion: Testicular choriocarcinoma is an exceptional cause of choroidal metastasis, potentially asymptomatic
and with specific clinical features. Radiotherapy can complement radical orchiectomy and chemotherapy, to
achieve full remission and maintain good vision.
Background
Intraocular metastases are present in up to 10% of
patients with systemic malignancies [1]. With tumour
cells spreading hematogenously, the posterior choroid is
frequently involved because of its rich vasculature [2]. In
females, the most common primary site is the breast,
whereas, in males, it is the lung.
Choriocarcinoma is a highly malignant metastatic
tumour, derived from undifferentiated placental tropho-
blasts (’gestational choriocarcinoma’)o rf r o mn o n - p l a -
cental totipotent cells, present in the testis, the ovary or
the pineal gland (’non gestational choriocarcinoma’). It
is characterized by the large amounts of chorionic gona-
dotropin produced.
Choriocarcinoma is a rare cause of choroidal metasta-
sis. Only 18 male patients have been reported on, and
most of them had a poor prognosis [2-4]. We present a
man who developed bilateral choroidal metastases from
a testicular choriocarcinoma under chemotherapy. The
ocular tumours regressed following irradiation. Four
years later, he is in remission and has excellent vision.
Case presentation
A 26-year-old man was referred to the Jules-Gonin Eye
Hospital with loss of vision and a non-pigmented
tumour in his left eye. In the previous two weeks, he
had been diagnosed with a left testicular tumour and
multiple metastases to the lung, brain, cerebellum, kid-
ney, liver and spine. Histopathology following left radical
orchiectomy had revealed a non-seminomatous testicu-
lar choriocarcinoma, positive for b-human chorionic
gonadotropin (b-HCG) and pancytokeratin, slightly posi-
tive for a-fetoprotein (AFP) while negative for carcino-
embryonic antigen (CEA). Serum levels were for b-HCG
271 052 U/l (normal < 3.0 U/l)), for AFP 0.9 ng/ml
(normal < 10 ng/ml) and for LDH 1757 U/l (normal <
450 U/l). He was receiving chemotherapy with bleomy-
cin, etoposide and cisplatin.
Visual acuity was 6/6 in the right eye and counting
fingers (CF) in the left eye. The left posterior fundus
showed a large amelanotic choroidal tumour associated
with a hemorrhagic retinal detachment. On B-scan
ultrasonography, thickness was 7 mm. In the right infer-
ior choroid, a second non pigmented, flat lesion was
also present, compatible with a diagnosis of bilateral
choroidal metastases (Figure 1).
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over 3 months’ time. Additionally, a stereotactic radio-
therapy of the spine and head was performed, the latter
including the posterior part of both eyes, using two lat-
eral accelerated photon fields of 6 MV with a total dose
of 30.80 Gy in 14 fractions.
After four years’ follow-up, the patient is in remission
without any evidence of metastases. All tumour markers
are within normal ranges (b-HCG < 0.1 U/l; AFP 1.2
ng/ml; LDH 284 U/l). Visual acuity is 6/6 in the right
and 6/9 in the left eye, both fundi showing a flat chor-
ioretinal scar (Figure 2).
Discussion
We describe a rare case of a patient with bilateral chor-
oidal metastases secondary to testicular choriocarci-
noma, successfully treated with chemo- and
radiotherapy.
MacDonald described the first case in 1936 [5]. A
meta-analysis of the literature in 2006 listed 14 male
Figure 1 Panoramic fundus pictures: Choroidal metastases from testicular choriocarcinoma at presentation: RE (Right Eye): a non
pigmented, flat lesion is discovered in the inferior choroid. LE (Left Eye): a large amelanotic tumour with associated hemorrhagic retinal
detachment occupies the posterior pole and is responsible for the vision loss.
Figure 2 Panoramic fundus pictures: Four years after chemo- and radiotherapy, both lesions have become flat chorioretinal scars.
Despite the unfavourable localisation of the left scar near the fovea, visual acuity has recovered to 6/9.
Guber et al. BMC Urology 2011, 11:24
http://www.biomedcentral.com/1471-2490/11/24
Page 2 of 3patients with testicular choriocarcinoma, as well as one
with mediastinal and one with retroperitoneal primary
choriocarcinoma, metastasizing to the choroids [2].
Since then, 2 more cases of choroidal metastases from
testicular choriocarcinoma have been reported [3,4].
Unlike other metastatic ocular disease, significant hae-
morrhage is associated with choriocarcinoma metastases
in more than 85% of cases and should raise suspicion
for this primary [2-4]. Kavanagh suggested a correlation
with upregulated levels of vascular endothelial growth
factor (VEGF) [2], thought to be involved in the devel-
opment of trophoblastic disease [6].
Prognosis of testicular germ cell tumours -including
choriocarcinoma- was poor until the introduction of cis-
platin-based chemotherapy in the mid-1970s [3]. Of the
18 male choriocarcinoma patients with choroidal metas-
tases, only 4 were reported to be cured, the first being
described in 1999 [7]. Two received only chemotherapy
[3,8], one had a supplementary brain radiotherapy
excluding the orbit [7] and one had ‘concurrent radio-
therapy to the whole skull and left eye’ [9], though no
report specifies the radiation dosage. In our patient, the
indication for stereotactic radiotherapy was based on the
fact that visual symptoms appeared after chemotherapy
had been initiated and that the blood-brain and blood-
eye barrier are reputed to be only partially permeable to
chemotherapeutics.
Visual acuity of the 4 surviving patients, who all had
unilateral choroidal metastases, ranges between CF and
6/12 [3,7-9]. Our patient, with bilateral metastatic dis-
ease, has a visual acuity of 6/6 and 6/9 respectively,
despite the parafoveal localization of the left tumour.
The coincidentally discovered asymptomatic tumour in
the right eye was treated before vision was affected.
Conclusion
We describe a rare case of a patient with testicular
choriocarcinoma presenting bilateral choroidal metas-
tases, with specific clinical features and one eye being
asymptomatic. Stereotactic radiotherapy of the skull and
spine complemented radical orchiectomy and che-
motherapy. After more than 4 years of follow up, he is
in full remission and has excellent vision.
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